Imunoterapia no cancro do pulmão: PD-L1, biomarcador preditivo?
Lung cancer remains one of the types of oncological disease that leads to greater morbimortality. Immunotherapy is one of the most recent advances relatively the therapeutic options available. As numerous clinical trials have been showing, this targeted therapy allows to increase the likelihood of a...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | por |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/128886 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/128886 |